Search bioRxivSearch

Biology subjects

Campbell, R. H.

Publications and source records attributed to Campbell, R. H..

2 recordsLinked to original sources

Analysis and Prediction of Unplanned Intensive Care Unit Readmission using Recurrent Neural Networks with Long Short-Term Memory

BackgroundUnplanned readmission of a hospitalized patient is an extremely undesirable outcome as the patient may have been exposed to additional risks. The rates of unplanned readmission are, therefore, regarded as an important performance indicator for the medical quality of a hospital and healthcare system. Identifying high-risk patients likely to suffer from readmission before release benefits both the patients and the medical providers. The emergence of machine learning to detect hidden patterns in complex, multi-dimensional datasets provides unparalleled opportunities to develop efficient discharge decision-making support system for physicians.\n\nMethods and FindingsWe used supervised machine learning approaches for ICU readmission prediction. We used machine learning methods on comprehensive, longitudinal clinical data from the MIMIC-III to predict the ICU readmission of patients within 30 days of their discharge. We have utilized recent machine learning techniques such as Recurrent Neural Networks (RNN) with Long Short-Term Memory (LSTM), by this we have been able incorporate the multivariate features of EHRs and capture sudden fluctuations in chart event features (e.g. glucose and heart rate) that are significant in time series with temporal dependencies, which cannot be properly captured by traditional static models, but can be captured by our proposed deep neural network based model. We incorporate multiple types of features including chart events, demographic, and ICD9 embeddings. Our machine learning models identifies ICU readmissions at a higher sensitivity rate (0.742) and an improved Area Under the Curve (0.791) compared with traditional methods. We also illustrate the importance of each portion of the features and different combinations of the models to verify the effectiveness of the proposed model.\n\nConclusionOur manuscript highlights the ability of machine learning models to improve our ICU decision making accuracy, and is a real-world example of precision medicine in hospitals. These data-driven results enable clinicians to make assisted decisions within their patient cohorts. This knowledge could have immediate implications for hospitals by improving the detection of possible readmission. We anticipate that machine learning models will improve patient counseling, hospital administration, allocation of healthcare resources and ultimately individualized clinical care.

bioinformatics

Predicting onset, progression, and clinical subtypes of Parkinson disease using machine learning

BackgroundThe clinical manifestations of Parkinson disease are characterized by heterogeneity in age at onset, disease duration, rate of progression, and constellation of motor versus nonmotor features. Due to these variable presentations, counseling of patients about their individual risks and prognosis is limited. There is an unmet need for predictive tests that facilitate early detection and characterization of distinct disease subtypes as well as improved, individualized predictions of the disease course. The emergence of machine learning to detect hidden patterns in complex, multi-dimensional datasets provides unparalleled opportunities to address this critical need.\n\nMethods and FindingsWe used unsupervised and supervised machine learning approaches for subtype identification and prediction. We used machine learning methods on comprehensive, longitudinal clinical data from the Parkinson Disease Progression Marker Initiative (PPMI) (n=328 cases) to identify patient subtypes and to predict disease progression. The resulting models were validated in an independent, clinically well-characterized cohort from the Parkinson Disease Biomarker Program (PDBP) (n=112 cases). Our analysis distinguished three distinct disease subtypes with highly predictable progression rates, corresponding to slow, moderate and fast disease progressors. We achieved highly accurate projections of disease progression four years after initial diagnosis with an average Area Under the Curve of 0.93 (95% CI: 0.96 {+/-} 0.01 for PDvec1, 0.87 {+/-} 0.03 for PDvec2, and 0.96 {+/-} 0.02 for PDvec3). We have demonstrated robust replication of these findings in the independent validation cohort.\n\nConclusionsThese data-driven results enable clinicians to deconstruct the heterogeneity within their patient cohorts. This knowledge could have immediate implications for clinical trials by improving the detection of significant clinical outcomes that might have been masked by cohort heterogeneity. We anticipate that machine learning models will improve patient counseling, clinical trial design, allocation of healthcare resources and ultimately individualized clinical care.

neuroscience